Quantbot Technologies LP Rocket Pharmaceuticals, Inc. Transaction History

Quantbot Technologies LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$15.07 - $24.05 $15,070 - $24,050	1,000 New	1,000 $20,000
Q3 2022 Nov 07, 2022	SELL	$12.37 - $18.41 $44,433 - $66,128	-3,592 Reduced 15.45%	19,657 $313,000
Q2 2022 Aug 09, 2022	BUY	$7.96 - $16.64 $185,062 - $386,863	23,249 New	23,249 $319,000
Q3 2021 Nov 09, 2021	SELL	$27.42 - $48.97 $8,226 - $14,691	-300 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$39.41 - $47.25 $100,889 - $120,960	-2,560 Reduced 89.51%	300 $13,000
Q1 2021 May 14, 2021	BUY	$43.34 - $65.91 $93,614 - $142,365	2,160 Added 308.57%	2,860 $126,000
Q4 2020 Feb 12, 2021	BUY	$23.3 - $59.57 $16,310 - $41,699	700 New	700 $38,000
Q3 2019 Nov 12, 2019	SELL	$10.85 - $14.78 $7,595 - $10,346	-700 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$15.0 - $19.81 $10,500 - $13,867	700 New	700 $10,000
Q2 2018 Aug 13, 2018	SELL	$14.58 - $23.0 $3,615 - $5,704	-248 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$11.68 - $19.19 $2,896 - $4,759	248 New	248 $4,000

213

93.1M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $851M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.